Cargando…

Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion

Detalles Bibliográficos
Autores principales:	Panet, François, Jung, Sungmi, Alcindor, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789206/ https://www.ncbi.nlm.nih.gov/pubmed/35050712 http://dx.doi.org/10.1200/PO.21.00303

Ejemplares similares

Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel SNX8-BRAF Gene Fusion
por: Offer, Katharine, et al.
Publicado: (2023)

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
por: Subbiah, Vivek, et al.
Publicado: (2014)

Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report
por: Alcindor, Thierry, et al.
Publicado: (2021)

OTHR-37. Pediatrics Cutaneous Reactions in Patient Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib
por: Gluck, Mirit, et al.
Publicado: (2022)

MYB/MYBL1::QKI fusion-positive diffuse glioma
por: Suh, Ye Yoon, et al.
Publicado: (2023)

Arabidopsis Raf-Like Mitogen-Activated Protein Kinase Kinase Kinase Gene Raf43 Is Required for Tolerance to Multiple Abiotic Stresses
por: Virk, Nasar, et al.
Publicado: (2015)

LGG-27. Molecular implications of mitogen-activated protein kinase pathway inhibition by the MEK inhibitor trametinib in BRAF-fusion-driven pediatric pilocytic astrocytoma
por: Sigaud, Romain, et al.
Publicado: (2022)

The QKI-6 and QKI-7 RNA Binding Proteins Block Proliferation and Promote Schwann Cell Myelination
por: Larocque, Daniel, et al.
Publicado: (2009)

Characterization and Expression of the Zebrafish qki Paralogs
por: Radomska, Katarzyna J., et al.
Publicado: (2016)

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations
por: Arbour, Kathryn C., et al.
Publicado: (2021)

Identification of a novel MTAP-RAF1 fusion in a soft tissue sarcoma
por: Hicks, J. Kevin, et al.
Publicado: (2018)

Two cases of spindle cell tumors with S100 and CD34 co-expression showing novel RAF1 fusions
por: Gong, Li-Hua, et al.
Publicado: (2022)

Comparison of Peptide Array Substrate Phosphorylation of c-Raf and Mitogen Activated Protein Kinase Kinase Kinase 8
por: Parikh, Kaushal, et al.
Publicado: (2009)

Qki is an essential regulator of microglial phagocytosis in demyelination
por: Ren, Jiangong, et al.
Publicado: (2020)

Spindle-Celled Sarcoma
Publicado: (1877)

MAP kinase meets mitosis: A role for Raf Kinase Inhibitory Protein in spindle checkpoint regulation
por: Rosner, Marsha Rich
Publicado: (2007)

Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation
por: Čepulytė, Rūta, et al.
Publicado: (2020)

Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review
por: Yu, Yang, et al.
Publicado: (2022)

A Role for Mitogen-activated Protein Kinase in the Spindle Assembly Checkpoint in XTC Cells
por: Wang, Xiao Min, et al.
Publicado: (1997)

Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events
Publicado: (1995)

Stability and flexibility of full-length human oligodendrocytic QKI6
por: Raasakka, Arne, et al.
Publicado: (2019)

Overexpression of the QKI Gene Promotes Differentiation of Goat Myoblasts into Myotubes
por: Chen, Sijia, et al.
Publicado: (2023)

Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation
por: Seo, Takuji, et al.
Publicado: (2020)

RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation
por: Le Calvez, Baptiste, et al.
Publicado: (2020)

Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
por: Cai, Cun-Liang, et al.
Publicado: (2019)

A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1
por: Allen, Allison J, et al.
Publicado: (2017)

The Fusion Oncogene FUS-CHOP Drives Sarcomagenesis of High-Grade Spindle Cell Sarcomas in Mice
por: Chen, Mark, et al.
Publicado: (2019)

Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy
por: Khoshkhoo, Sattar, et al.
Publicado: (2023)

Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation
por: Dotsu, Yosuke, et al.
Publicado: (2020)

Spindle-Celled Sarcoma of the Hard Palate
por: Greer, W. J.
Publicado: (1900)

The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
por: Zong, Feng-Yang, et al.
Publicado: (2014)

MYB-QKI drives childhood brain tumors via tripartite mechanism
por: Jain, Payal, et al.
Publicado: (2016)

Targeting QKI-7 in vivo restores endothelial cell function in diabetes
por: Yang, Chunbo, et al.
Publicado: (2020)

The Emerging Roles of the RNA Binding Protein QKI in Cardiovascular Development and Function
por: Chen, Xinyun, et al.
Publicado: (2021)

Qki regulates myelinogenesis through Srebp2-dependent cholesterol biosynthesis
por: Zhou, Xin, et al.
Publicado: (2021)

Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an STRN-NTRK2 Fusion
por: Wu, Lawrence W., et al.
Publicado: (2018)

Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1
por: Hemming, Matthew L., et al.
Publicado: (2020)

Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells
por: Abd El Maksoud, Ahmed I., et al.
Publicado: (2019)

Targeting the Raf kinases in human cancer: the Raf dimer dilemma
por: Durrant, David E, et al.
Publicado: (2018)

A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy
por: Williams, Casey B, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hsrfmg1ev5qiobv2ledt6n4onn